A comprehensive case-control study evaluated single-nucleotide polymorphisms (SNPs) in key TGF-β pathway genes, suggesting that these genetic variations could modulate the risk of developing bladder cancer [55]. Here, TGFB1 is linked to urinary bladder carcinoma.